The largest database of trusted experimental protocols

Psma 617

Manufactured by MedChemExpress
Sourced in United States

PSMA-617 is a radiopharmaceutical compound used for the detection and imaging of prostate-specific membrane antigen (PSMA) expressing cells. It is a synthetic molecule that can bind to PSMA, a protein that is overexpressed in prostate cancer cells. PSMA-617 can be radiolabeled with various isotopes for use in diagnostic and therapeutic applications.

Automatically generated - may contain errors

2 protocols using psma 617

1

Radiolabeling of PSMA-617 with Lutetium-177

Check if the same lab product or an alternative is used in the 5 most similar protocols
In short, following a previously published protocol [12 (link),19 (link),20 (link)], 100 µL of sterile sodium acetate solution (0.4 M, pH 5.5) and 1.25 µL ascorbic acid solution (20% w/w) were added to ca 30–40 µL (1.25 GBq in total) of non-carrier added Lutetium-177 (ITM Isotope Technologies Munich, Garching, Germany). To this solution, 20 nmol (volume circa 2 µL) of PSMA-617 (MedChemExpress, Monmouth Junction, NJ, USA) were added and labeled by incubating on a shaker at 95 °C for 15 min after which the reaction was terminated by cooling to room temperature. At 0 and 15 min, respectively, 1 µL of the solution was added to an instant thin layer chromatography (iTLC) strip. Sodium citrate solution (0.2 M, pH 2) was used as mobile phase, and the percentage of free 177Lu (which migrates with the solvent front) was determined by analyzing the iTLC strips with a phosphor imager system (Cyclone Plus Phosphor Imager, PerkinElmer, Inc., Waltham, MA, USA). A sterile 0.9% sodium chloride solution was added, and the radioligand diluted (1:3 or 1:7), a sample for iTLC taken, and pH tested before injections in mice. 177Lu-PSMA was labeled at a specific activity of 62 MBq/nmol (judged most effective for therapy by Fendler et al. [19 (link)]), and the radiochemical purity of the radioligand was >99%.
+ Open protocol
+ Expand
2

Pharmacological Modulators of Glutamatergic Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
PSMA-617 (vipivotide tetraxetan, HY-117410), 2-PMPA (HY-100788) were purchased from MedchemExpress (Monmouth Junction, NJ, USA). The sulforhodamine B (SRB) based In vitro toxicology assay kit (TOX6) and L-glutamic acid monosodium salt hydrate (monosodium glutamate, MSG, G5889) were purchased from Sigma-Aldrich (Overijse, Belgium). Kynurenic acid (S4719), memantine HCl (S2043), capric acid (S6906) and (-)-Dizocilpine (MK 801) maleate (S2857) were purchased from SelleckChem (Planegg, Germany). UBP 302 (2079) was purchased from Tocris Biosciences (Abingdon, UK). (RS)-MCPG (sc-202325), (RS)-CPPG (sc-203448), LY341495 (sc-361244A) and UBP1112 (sc-204368) were purchased from Santa Cruz Biotechnologies (Heidelberg, Germany). Compounds were dissolved either in H2O, 0.05 M NaOH or DMSO.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!